Posts in tag

TheStreet


Cardiff Oncology (CRDF)  is a small oncology company whose shares have been caught in the biotech selloff through the first six months of 2022. Now, at CRDF’s current trading levels, I see the stock as setup for a compelling risk/reward trade. In fact, with the right option strategy, you can get your potential entry level down to significantly below the …

The Dow Jones Industrial Average ended down Friday, but held onto most of the week’s gains following reports that President Donald Trump ordered, but then rescinded, an airstrike on military installations in Iran. Shares of Canopy Growth (CGC – Get Report)  tumbled after the company posted a wider loss on better-than expected revenue. Canopy Growth is Real …

The S&P 500 set an intraday record high Thursday as investors were spurred on by signals of lower interest rates from the Federal Reserve. Oracle (ORCL – Get Report) rose after the enterprise software company topped analysts’ earnings and revenue expectations for its fiscal fourth quarter, and said first-quarter profit likely would top forecasts. Oracle …